LU91973I2

Dermal penetration enhancers and drug delivery systems involving same

Abstract

A transdermal drug delivery system which comprises at least one physiologically active agent or prodrug thereof and at least one dermal penetration enhancer, characterised in that the dermal penetration enhancer is a safe skin-tolerant ester sunscreen. A non-occlusive, percutaneous or transdermal drug delivery system which comprises: (i) an effective amount of at least one physiologically active agent or prodrug thereof; (ii) at least one non-volatile dermal penetration enhancer, and (iii) at least one volatile liquid; characterized in that the dermal penetration enhancer is adapted to transport the physiologically active agent across a dermal surface or mucosal membrane of an animal, including a human, when the volatile liquid evaporates, to form a reservoir or depot of a mixture comprising the penetration enhancer and the physiologically active agent or prodrug within said surface or membrane; and the dermal penetration enhancer is of low toxicity to, and is tolerated by, the dermal surface or mucosal membrane of the animal.

Term

5.5 yearsto projected expiry

Projected expiry 4 April 2032, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

69 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
PN814496AustraliaA
9700091AustraliaW

Members69

Family members, oldest first
DocumentOfficeKind
CA2244089A1CanadaA1
WO9729735A1World Intellectual Property Organization (WIPO)A1
AU1713497AAustraliaA
EP0901368A1European Patent Office (EPO)A1
AU706967B2AustraliaB2
NZ330942ANew ZealandA
AU5258999AAustraliaA
KR19990087057ARepublic of KoreaA
HK1018884A1Hong Kong, ChinaA1
EP0901368A4European Patent Office (EPO)A4
JP2000504697AJapanA
US6299900B1United States of AmericaB1
US2002028235A1United States of AmericaA1
US2004009214A1United States of AmericaA1
US2004013620A1United States of AmericaA1
US2004013621A1United States of AmericaA1
US2004028625A1United States of AmericaA1
US2004028725A1United States of AmericaA1
US2004081684A1United States of AmericaA1
US2004096405A1United States of AmericaA1
US2004146469A1United States of AmericaA1
US6818226B2United States of AmericaB2
US6916486B2United States of AmericaB2
US6916487B2United States of AmericaB2
US6923983B2United States of AmericaB2
US6929801B2United States of AmericaB2
US6964777B2United States of AmericaB2
US6998138B2United States of AmericaB2
EP0901368B1European Patent Office (EPO)B1
DE69735804D1GermanyD1
ATE324865T1AustriaT1
EP1674068A1European Patent Office (EPO)A1
US7094422B2United States of AmericaB2
DK0901368T3DenmarkT3
PT901368EPortugalE
HK1087355A1Hong Kong, ChinaA1
ES2262173T3SpainT3
DE69735804T2GermanyT2
KR100528602B1Republic of KoreaB1
US2007071803A1United States of AmericaA1
EP1769785A1European Patent Office (EPO)A1
US2007077288A1United States of AmericaA1
HK1101553A1Hong Kong, ChinaA1
JP2007326867AJapanA
US2008131494A1United States of AmericaA1
US7387789B2United States of AmericaB2
US2008152597A1United States of AmericaA1
EP1674068B1European Patent Office (EPO)B1
ATE410136T1AustriaT1
US7438203B2United States of AmericaB2
DE69739037D1GermanyD1
PT1674068EPortugalE
JP4213211B2JapanB2
DK1674068T3DenmarkT3
ES2314538T3SpainT3
CA2244089CCanadaC
EP1769785B1European Patent Office (EPO)B1
ATE472997T1AustriaT1
DE69739931D1GermanyD1
PT1769785EPortugalE
DK1769785T3DenmarkT3
ES2348313T3SpainT3
US8071075B2United States of AmericaB2
LU91971I2LuxembourgI2
LU91972I2LuxembourgI2
LU91973I2This recordLuxembourgI2
DE122012000019I1GermanyI1
DE122012000020I1GermanyI1
DE122012000021I1GermanyI1